AlaghehbandanRAgaimyAAliL, et al.A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022). Mod Pathol. 2022;35(12):2023–2024.
2.
ColecchiaM. Obituary Prof. Ondrej Hes. Virchows Arch. 2022;481(6):981–982.
3.
HesOBrunelliMMichalM, et al.Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol. 2006;10(3):133–139.
4.
HesOMichalMSimaR, et al.Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features. Virchows Arch. 2008;452(3):285–293.
5.
HesOMichalMSimaR, et al.Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features. Virchows Arch. 2008;452(2):193–200.
6.
PeterssonFGatalicaZGrossmannP, et al.Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch. 2010;456(4):355–365.
7.
KurodaNTamuraMHesOMichalMGatalicaZ. Chromophobe renal cell carcinoma with neuroendocrine differentiation and sarcomatoid change. Pathol Int. 2011;61(9):552–554.
8.
KurodaNTamuraMHesO,et al.Chromophobe renal cell carcinoma with prominent lymph node metastasis and polysomy of chromosome 21: poorly differentiated form or “presarcomatoid” form?Med Mol Morphol. 2011;44(3):168–173.
9.
KurodaNTanakaAYamaguchiT, et al.Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med Mol Morphol. 2013;46(1):49–55.
10.
SpergaMMartinekPVanecekT, et al.Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases. Virchows Arch. 2013;463(4):563–573.
11.
PeckovaKMartinekPOheC, et al.Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature. Ann Diagn Pathol. 2015;19(4):261–268.
12.
FoixMPDunatovAMartinekP, et al.Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. Virchows Arch. 2016;469(6):669–678.
13.
HesOVanecekTPerez-MontielDM, et al.Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation--a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases. Virchows Arch. 2005;446(4):383–393.
14.
BrunelliMGobboSCossu-RoccaP, et al.Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol. 2007;20(3):303–309.
15.
PeckovaKGrossmannPBulimbasicS, et al.Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity. Ann Diagn Pathol. 2014;18(5):291–296.
16.
HesOComperatEMRioux-LeclercqN. Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review. Ann Diagn Pathol. 2016;21:59–64. doi: 10.1016/j.anndiagpath.2015.11.003
17.
PeterssonFGrossmannPHoraM, et al.Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma. Hum Pathol. 2013;44(7):1412–1420.
18.
PeterssonFMartinekPVanecekT, et al.Renal cell carcinoma with leiomyomatous stroma: a group of tumors with indistinguishable histopathologic features, but 2 distinct genetic profiles: next-generation sequencing analysis of 6 cases negative for aberrations related to the VHL gene. Appl Immunohistochem Mol Morphol. 2018;26(3):192–197.
19.
MichalMHesONemcovaJ, et al.Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454(1):89–99.
20.
TrpkovKHesOAgaimyA, et al.Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol. 2016;40(7):865–875.
21.
AlaghehbandanRStehlikJTrpkovK, et al.Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma. Ann Diagn Pathol. 2017;29:17–22. doi: 10.1016/j.anndiagpath.2017.04.007
22.
TrpkovKAbou-OufHHesO, et al.Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity. Am J Surg Pathol. 2017;41(10):1299–1308.
23.
FarcasMGatalicaZTrpkovK, et al.Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. Mod Pathol. 2022;35(3):344–351.
24.
TrpkovKBonertMGaoY, et al.High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex. Histopathology. 2019;75(3):440–442.
25.
TrpkovKWilliamsonSRGaoY, et al.Low-grade oncocytic tumour of kidney (CD117–negative, cytokeratin 7-positive): a distinct entity?Histopathology. 2019;75(2):174–184.
26.
HesOTrpkovK. Do we need an updated classification of oncocytic renal tumors? : emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities. Mod Pathol. 2022;35(9):1140–1150.
27.
TretiakovaMS. Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities. Adv Anat Pathol. 2022;29(3):131–140.
AlaghehbandanRWilliamsonSRMcKenneyJKHesO. The histologic diversity of chromophobe renal cell carcinoma with emphasis on challenges encountered in daily practice. Adv Anat Pathol. 2022;29(4):194–207.
30.
SaeedFOsunkoyaAO. Secondary tumors of the kidney: a comprehensive clinicopathologic analysis. Adv Anat Pathol. 2022;29(4):241–251.
31.
TrpkovKWilliamsonSRGillAJ, et al.Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34(6):1167–1184.
32.
TrpkovKHesOWilliamsonSR, et al.New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34(7):1392–1424.
